Use the PDF link above to access the media release. The HTML version will be available shortly.

The Panel has decided to conduct proceedings and made interim orders¹ in response to an application dated 6 November 2025 by Mayne Pharma Group Limited (Mayne) in relation to its own affairs (see TP25/93).

The Panel has consented to a request from Mr Benjamin Pauley to withdraw his application to the Panel dated 27 October 2025 in relation to the affairs of Maronan Metals Limited (ASX: MMA) (Maronan) (see TP25/092).

The Panel is satisfied that it is not against the public interest to consent to the applicant withdrawing his application. The Panel does not propose to publish reasons in relation to this matter.

The Panel has received an application from Mayne Pharma Group Limited (Mayne) in relation to its affairs.

Details of the application, as submitted by the applicant, are below.

A sitting Panel has not been appointed at this stage and no decision has been made whether to conduct proceedings. The Panel makes no comment on the merits of the application.

The Panel has received an application from Mr Ben Pauley in relation to the affairs of Maronan Metals Limited (ASX: MMA) (Maronan).

Details of the application, as submitted by the applicant, are below.

A sitting Panel has not been appointed at this stage and no decision has been made whether to conduct proceedings. The Panel makes no comment on the merits of the application.

Details

Maronan is an ASX listed mining company holding silver, lead, copper and gold deposits.